NKTR
Nektar TherapeuticsNASDAQHealthcare$76.99+1.69%ClosedMarket Cap: $1.56B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
0
Sales
3
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$3.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Feb 20 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 180 | $73.00 | 21,174 |
| Fri Feb 20 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 423 | $73.00 | 75,489 |
| Thu Jan 22 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 3,867 | $35.67 | 21,354 |
| Tue Dec 23 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 6,250 | $0.00 | 25,221 |
| Tue Dec 23 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 25,000 | $43.48 | 25,000 |
| Tue Dec 23 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 86,667 | $43.48 | 86,667 |
| Tue Dec 23 | ROBIN HOWARD W | director, officer: President & CEO | Sell | 21,667 | $0.00 | 75,912 |
| Tue Nov 25 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 2,666 | $0.00 | 20,128 |
| Tue Nov 25 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 1,157 | $54.28 | 18,971 |
| Tue Nov 25 | Zalevsky Jonathan | officer: Chief R&D Officer | Sell | 4,766 | $281.25 | 4,766 |